Dr. Andrew H Ko, MD
Claim this profileUniversity of California San Francisco
Studies Pancreatic Cancer
Studies Cancer
9 reported clinical trials
23 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
2Cancer
PD-L1 positive
PD-L1 negative
DKK1 negative
Affiliated Hospitals
Clinical Trials Andrew H Ko, MD is currently running
Ivaltinostat + Capecitabine
for Pancreatic Cancer
This trial tests ivaltinostat with capecitabine in patients with advanced pancreatic cancer who have not worsened after initial treatment. The goal is to find a safe and effective dose and to see if this combination can better control the cancer. Capecitabine is a medication that is converted into another drug in the body, showing better selectivity and tolerability in tumor tissues.
Recruiting3 awards Phase 1 & 211 criteria
Perioperative Chemotherapy
for Pancreatic Cancer
This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy drugs, such as fluorouracil, irinotecan, leucovorin, and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving chemotherapy before and after surgery (perioperatively) may work better in treating patients with pancreatic cancer compared to giving chemotherapy after surgery (adjuvantly).
Recruiting4 awards Phase 318 criteria
More about Andrew H Ko, MD
Clinical Trial Related5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Andrew H Ko, MD has experience with
- Gemcitabine
- Capecitabine
- Oxaliplatin
- Fluorouracil
- Leucovorin Calcium
- Hydroxychloroquine
Breakdown of trials Andrew H Ko, MD has run
Pancreatic Cancer
Cancer
Pancreatic Carcinoma
Stomach Cancer
Cervical Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew H Ko, MD specialize in?
Andrew H Ko, MD focuses on Pancreatic Cancer and Cancer. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Andrew H Ko, MD currently recruiting for clinical trials?
Yes, Andrew H Ko, MD is currently recruiting for 3 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Andrew H Ko, MD has studied deeply?
Yes, Andrew H Ko, MD has studied treatments such as Gemcitabine, Capecitabine, Oxaliplatin.
What is the best way to schedule an appointment with Andrew H Ko, MD?
Apply for one of the trials that Andrew H Ko, MD is conducting.
What is the office address of Andrew H Ko, MD?
The office of Andrew H Ko, MD is located at: University of California San Francisco, San Francisco, California 94158 United States. This is the address for their practice at the University of California San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.